Top compounds associated with response to NXF2B


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.072 0.05
mRNA manumycin A CTRPv2 pan-cancer AAC 0.061 0.05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.05
mRNA ML210 CTRPv2 pan-cancer AAC -0.063 0.05
mRNA BRD-K48334597 CTRPv2 pan-cancer AAC -0.14 0.06
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.091 0.06
mRNA BRD4132 CTRPv2 pan-cancer AAC -0.071 0.06
mRNA ML258 CTRPv2 pan-cancer AAC -0.07 0.06
mRNA Rapamycin gCSI pan-cancer AAC -0.099 0.06
mRNA ML203 CTRPv2 pan-cancer AAC -0.07 0.06
Download CSV